Skip to main content
Clinical Trials/CTRI/2023/03/050329
CTRI/2023/03/050329Not yet recruitingPhase 4

A comparative clinical study to evaluate the effect of vatari guggulu and shatpushpadi churna with simhanada guggulu in the management of amavata w.s.r. to rheumatoid arthritis

Rajiv Gandhi Govt Post Graduate Ayrvedic College and Hospital Paprola0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patient willing for study
  • Age group 30-70 years will be selected for the study
  • Patients with signs and symptoms of Amavatar wsr. to Rheumatoid Arthritis as described in classical texts and fulfill the diagnostic criteria.

Exclusion Criteria

  • 1. Patients not willing for the study.
  • 2. Patients below age of 30 years and above 70 years of age.
  • 3. Patients suffering from cardiac, respiratory, P.T.B. Malignancy, Patient already taking chemotherapy, radiotherapy. Pregnant and Lactating women. Allergy to the research drug or any other condition considered to be Unfit for enrollment in the trial.

Investigators

Sponsor
Rajiv Gandhi Govt Post Graduate Ayrvedic College and Hospital Paprola

Similar Trials